Tear Film Break-Up Time Evaluation of FID 114657
NCT01023464 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2016-11-18
Summary
To evaluate the effects of FID 114657 on tear film break-up time in dry eye patients.
Conditions
- Dry Eye
Interventions
- OTHER
-
FID114657
artificial tears
- OTHER
-
SootheXP Emollient (Lubricant) Eye Drops
artificial tears
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2010-01-31
More Related Trials
-
Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer Thickness
NCT01066988 ·Status: COMPLETED ·Phase: NA
-
Evaluation of FID 114657 in Dry Eye Subjects
NCT01079858 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Evaluation of the Nighttime Retention of Effect of an Investigational Lubricant Eye Drop (FID 115958D)
NCT01165164 ·Status: COMPLETED ·Phase: NA
-
A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)
NCT01294956 ·Status: COMPLETED ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Artificial Tears, Tear Lipids and Tear Film Dynamics
NCT05705518 ·Status: COMPLETED ·Phase: PHASE4
-
Lipid Layer Thickness Pre and Post Lid Scrubs With Cliradex
NCT02493244 ·Status: COMPLETED ·Phase: NA
-
Effect of Controlled Adverse Environment (CAE) on Tear Film Stability
NCT01547936 ·Status: COMPLETED
-
Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
NCT00758784 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease
NCT06444516 ·Status: COMPLETED ·Phase: NA
-
Tear Lipid Layer Thickness With Emollient Eye Drops
NCT03380624 ·Status: COMPLETED ·Phase: PHASE4
-
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
NCT04041856 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Tear Film Break-up Time After Instillation of Artificial Tears
NCT00681265 ·Status: COMPLETED ·Phase: NA
-
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
NCT01682460 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency
NCT01688726 ·Status: COMPLETED ·Phase: NA
-
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
NCT01212471 ·Status: COMPLETED ·Phase: PHASE3
-
Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
NCT04711642 ·Status: UNKNOWN ·Phase: PHASE3
-
An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations
NCT06538662 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541 ·Status: COMPLETED ·Phase: NA
-
The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects
NCT01718028 ·Status: COMPLETED ·Phase: NA
-
Topical Menthol For Tear Secretion
NCT07109609 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Safety and Efficacy of NovaTears® + Omega-3 (0.2%) Eye Drops on Signs and Symptoms of Dry Eye
NCT04521465 ·Status: COMPLETED
-
Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation
NCT04633863 ·Status: COMPLETED ·Phase: NA
-
Tear Dynamics After Restasis Treatment in Dry Eye Patients
NCT00706940 ·Status: COMPLETED